Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Karlan

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Gynecologic Oncology|January 22, 2022
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutationYue Yin Xia, Jacek Gronwald, Beth Karlan, et al.
British Journal of Cancer|May 2, 2025
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variantJoanne Kotsopoulos, Christopher A Maxwell, Jan Lubinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyEric Winer, Julie Gralow, Lisa Diller, et al.
Hereditary Cancer in Clinical Practice|May 14, 2024
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutationsSteven A Narod, Kelly Metcalfe, Amy Finch, et al.
Breast Cancer Research and Treatment|February 14, 2019
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Journal of the National Cancer Institute|June 27, 2024
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriersSteven A Narod, Jacek Gronwald, Beth Karlan, et al.
British Journal of Cancer|November 29, 2023
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysisKelly Metcalfe, Tomasz Huzarski, Jacek Gronwald, et al.
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Breast Cancer Research and Treatment|July 11, 2023
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Breast Cancer Research and Treatment|January 25, 2014
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Pal Moller, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Gynecologic Oncology|January 22, 2022
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutationYue Yin Xia, Jacek Gronwald, Beth Karlan, et al.
British Journal of Cancer|May 2, 2025
Parity, breastfeeding, and the risk of early-onset breast cancer in women with a BRCA1 pathogenic variantJoanne Kotsopoulos, Christopher A Maxwell, Jan Lubinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2008
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical OncologyEric Winer, Julie Gralow, Lisa Diller, et al.
Hereditary Cancer in Clinical Practice|May 14, 2024
The risk of skin cancer in women who carry BRCA1 or BRCA2 mutationsSteven A Narod, Kelly Metcalfe, Amy Finch, et al.
Breast Cancer Research and Treatment|February 14, 2019
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Henry T Lynch, et al.
Journal of the National Cancer Institute|June 27, 2024
Incidence of peritoneal cancer after oophorectomy among BRCA1 and BRCA2 mutation carriersSteven A Narod, Jacek Gronwald, Beth Karlan, et al.
British Journal of Cancer|November 29, 2023
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysisKelly Metcalfe, Tomasz Huzarski, Jacek Gronwald, et al.
Journal of the National Cancer Institute|September 8, 2016
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation CarriersJoanne Kotsopoulos, Tomasz Huzarski, Jacek Gronwald, et al.
Breast Cancer Research and Treatment|July 11, 2023
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutationJoanne Kotsopoulos, Jacek Gronwald, Tomasz Huzarski, et al.
Breast Cancer Research and Treatment|January 25, 2014
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Pal Moller, et al.
Pageof 9